Four groups of researchers from the United States, the Netherlands, and the United Kingdom have recently examined large groups of people with
Parkinson’s disease and people without Parkinson’s disease who served as control groups. The researchers determined how often a
mutation in the
LRRK2 gene occurs in some people with what appeared to be sporadic, or unexplained, Parkinson’s disease.